SEC Form 4 · accession 0001237899-15-000051
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leonard S Schleifer
Officer — President & CEO · Director
Period of report
Sep 2, 2015
Accepted (ET)
Sep 3, 2015 · 4:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 2, 2015 | M | 7,226 | $402.69 | A | 49,313 | D | |
| Common Stock | Sep 2, 2015 | F | 5,745 | $506.37 | D | 43,568 | D | |
| Common Stock | Sep 2, 2015 | F | 762 | $506.37 | D | 42,806 | D | |
| Common Stock | holding | — | — | — | 5,681 | I | By 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $402.69 | Sep 2, 2015 | M | 7,226 | D | Apr 27, 2015 | Dec 19, 2015 | Common Stock | 7,226 | 0 | D |
Explanation of responses
- F1Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).